Treatment with capmatinib led to greatly reduced levels of phosphorylated MET, Erk and Akt in initial neoplasms of PD animals, whereas crizotinib treatment induced a less complete reduction compared to vehicle-treated mice (Fig. 3d,e and f and Supplementary Fig. 3; Additional File 6). Here, AKT1 is linked to neoplasm.